Adequan® Shortage Update

Supply of Adequan® IM and Adequan® IA – the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness in horses – was interrupted last year, resulting shortages in the marketplace.

Luitpold Animal Health, who manufacture these products have announced that they have been working closely with the FDA to assure that Adequan® is made available very soon, possibly the end of this month.

Last year, Luitpold renovated and upgraded its Shirley, New York manufacturing facility, which led to delays in production. The company has established www.adequan.com where consumers can register to receive future communications and updates on this matter. Information is also available at 1-800-458-0163.

More from Horse-Canada:

B.C. Wild Horses Featured in The Wild Ones T.V. Series

A series on the History channel, called The Wild Ones, features the Qayus, a breed of wild horse in B.C., and the Xeni Gwet’in people who watch over them.

Horse Canada Magazine Goes Digital Only in 2020

With the start of the new decade, Horse Canada is evolving to better meet our readers’ needs, with more modern and timely digital delivery.

The Role of Tradition vs Science in Handling Horses

A group of researchers from Australia recently conducted a study to investigate human interactions with horses, looking at tradition vs science.

The Annual Gobi Desert Cup Kicks Off Next Week

The annual Gobi Desert Cup will be held from August 28 to September 6. Find out which riders from around the world are set take on the challenge.